<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease is a systemic <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disorder</z:e> without a specific treatment that is chosen on the basis of the type and severity of manifestation in the organ involved </plain></SENT>
<SENT sid="1" pm="."><plain>More recently, biological agents like etanercept have emerged as possible therapeutic alternatives in patients resistant to conventional therapy </plain></SENT>
<SENT sid="2" pm="."><plain>We describe the successful treatment for 1 year of resistant <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease with etanercept </plain></SENT>
<SENT sid="3" pm="."><plain>After the administration of this drug, a resolution of the clinical, laboratory and instrumental picture was achieved with a suspension of immunosuppressive treatments and a reduction of steroid dependency (5 mg/day) </plain></SENT>
<SENT sid="4" pm="."><plain>No side effects were observed </plain></SENT>
</text></document>